TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04678453

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SNK01
Description: Patient-specific ex vivo expanded autologous natural killer cells

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SNK01
Description: Patient-specific ex vivo expanded autologous natural killer cells

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SNK01
Description: Patient-specific ex vivo expanded autologous natural killer cells

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SNK01
Description: Patient-specific ex vivo expanded autologous natural killer cells
Study: NCT03877874

Intervention type: DRUG
Intervention: Aironyl syrup(Terbutaline sulfate) + Epidrone syrup(Dexamethone)
Description: Aironyl syrup(Terbutaline sulfate ................. 1.5mg) 0.075-0.29 mg/ kg body weight 3 times daily Apidone syrup(Dexamethone) (0.02 to 0.3 mg per kilogram (kg) of body weight per day, divided and taken 3 or 4 times a day)
Study: NCT06206733

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASKB589
Description: ASKB589 will be administered as a minimum 3-hour IV infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Oxaliplatin will be administered as a minimum 2-hour IV infusion

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Oxaliplatin
Description: Oxaliplatin will be administered as a minimum 2-hour IV infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Capecitabine will be administered orally twice daily (bid).

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Capecitabine
Description: Capecitabine will be administered orally twice daily (bid).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Tislelizumab will be administered every 3 weeks Intravenous infusion on day 1 of each cycle.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Tislelizumab
Description: Tislelizumab will be administered every 3 weeks Intravenous infusion on day 1 of each cycle.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered as a minimum 3-hour IV infusion
Study: NCT06358313

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Atorvastatin 40mg
Description: The atorvastatin group consisted of 300 patients who received 40 mg daily atorvastatin for 3 months, an open-label aspirin at a loading dose of 75 to 300 mg, and then 75 mg daily till the end of the 3 months, and open-label clopidogrel at a loading dose of 300 mg and then 75 mg daily till the end of the 3 months.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rosuvastatin 20mg
Description: The rosuvastatin group consisted of 300 patients who received 40 mg daily rosuvastatin for 3 months, an open-label aspirin at a loading dose of 75 to 300 mg, and then 75 mg daily till the end of the 3 months, and open-label clopidogrel at a loading dose of 300 mg and then 75 mg daily till the end of the 3 months.
Study: NCT05085964

Intervention type: DRUG
Group type: OTHER
Intervention: RNA antisense oligonucleotide for intravitreal injection
Description: QR-421a will be first administered to the fellow eye (as defined in the preceding study), and will be repeated every 6 months.~Treatment of the study eye (as defined in the preceding study) can commence 3 months (9 months for subjects from study PQ-421a-001) after the treatment of the fellow eye has been initiated and will be repeated every 6 months as well.~Continued subject treatment in this study will be pursued provided that the benefit-risk balance is positive for the individual subject.
Study: NCT05707637

Intervention type: OTHER
Intervention: Ablation
Description: Unipolar and bipolar ablation
Study: NCT06442553

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GRR laser
Description: A total of 15 sessions were applied to each patient for three weeks, five times per week.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nd:YAG laser
Description: A total of 10 sessions, five sessions per week, were applied

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Nd:YAG laser
Description: A total of 10 sessions, five sessions per week, were applied
Study: NCT05784233

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relevance (Likelihood Salient Item is Target)
Description: The proportion of trials, when the salient visual item is present in the array, where the salient item is the search target.
Study: NCT06143618

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: escape room games
Description: The escape room game will include a patient scenario of four female patients who are victims of violence and apply to different clinics. Necessary equipment and materials will be provided and stations will be established where four female patients who are victims of violence will be evaluated. In the game, each student will contact the patient at only one station and evaluate signs and symptoms of violence. The activities at the stations will be carried out together as a group. The group, which completes the tasks and activities and collects the puzzle pieces that will lead to the code of the lock, will complete the puzzle and enter the number codes on it into the key of the locked box on the table (4 numerical codes received), open the box and get the message 'you can escape'. The group with the most time left at the end of the game will come first and will be rewarded.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: role playing
Description: In the role play application, there will be scenarios of four female patients who are victims of violence and apply to different clinics. Before the role play activities, students will be asked to form groups of 4-5 people, and each week, a group will be asked to choose one of the four scenarios given by lot and improvise the case-based role play activity within 40 minutes. Before the role play application, the materials that may be required for the students (clothes, materials, etc.) and the preparation of the environment (hospital, polyclinic, etc.) will be provided by the researchers in accordance with the activity to be enacted. At the end of the role play activities, students will be able to express, evaluate and discuss their feelings and thoughts within and between groups.
Study: NCT05784233

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relevance (Likelihood Salient Item is Target)
Description: The proportion of trials, when the salient visual item is present in the array, where the salient item is the search target.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relevance (Likelihood Salient Item is Target)
Description: The proportion of trials, when the salient visual item is present in the array, where the salient item is the search target.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relevance (Likelihood Salient Item is Target)
Description: The proportion of trials, when the salient visual item is present in the array, where the salient item is the search target.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relevance (Likelihood Salient Item is Target)
Description: The proportion of trials, when the salient visual item is present in the array, where the salient item is the search target.
Study: NCT00105859

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Education and Counseling
Study: NCT05810012

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PENG block
Description: 10ml of 0.125% isobaric bupivacaine injected

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FICB Block
Description: 20ml of 0.125% isobaric bupivacaine injected
Study: NCT06256601

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Theracal (calcium silicate)
Description: selective removal to soft dentin, restorations with calcium silicate

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Dycal (calcium hydroxide)
Description: selective removal to soft dentin, restoration with calcium hydroxide
Study: NCT06481293

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Diode laser therapy
Description: Dual wavelength laser diode therapy device

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Alveogyl dressing
Description: Alveogyl is a haemostatic-analgesic alveolar dressing
Study: NCT05304130

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Otilimab
Description: Otilimab will be administered via pre-filled syringe.
Study: NCT06133608

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MOBILIZATION TRAINING
Description: Things to consider in the hospital in the early period after surgery: The first day in the hospital after surgery, the importance of the abduction pillow and early mobilization,~* Exercises performed in bed in the early period after surgery: Exercises such as ankle pump, ankle rotation, bed-supported knee bending, hip contraction, opening exercise, thigh exercise, straight leg raise,~* Early standing up: Activities such as sitting in bed or on a chair, standing up with the help of a walker, walking,~* Exercises performed while standing: Exercises such as lifting the knee, opening the leg to the side,~* Daily living activities: It will provide information on regulating ADLs such as bathing, dressing, using the toilet, getting into and driving the car, going up and down stairs, eating, sleeping, doing housework, sexual life, and information about the safety precautions that should be taken at home.
Study: NCT05504980

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Repositioning
Description: Patients in the intervention group will be given 30 degrees right lateral, supine, and 30 degrees left lateral positions, 1 hour apart, respectively.
Study: NCT05969041

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MT-302 (A)
Description: MT-302 is an investigational drug
Study: NCT06314438

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Care Project
Description: Caregivers will be administered the Family Care Project workbook.
Study: NCT06198231

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pilates exercises
Description: Pilates exercises

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Flexibility ,strength and endurance excercises
Description: flexibility ,strength and endurance excercises
Study: NCT05394870

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: manual lymphatic drainage (massage)
Description: Patients will begin treatment with manual lymphatic drainage in the affected extremity. In this context, while the patients are in the supine hook position, lymph drainage will be applied first to the neck and then to the abdomen. After the stimulation of the central lymph nodes, the lymph circulation will be increased by stimulating the axillary lymph nodes of the relevant region. First, the proximal part will be drained and it will be advanced towards the distal. Drainage will be repeated depending on the edema at the distal forearm-wrist level.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Splint treatment
Description: The splint routinely given to patients diagnosed with mild to moderate carpal tunnel syndrome will be given to both groups in these patients

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Splint treatment
Description: The splint routinely given to patients diagnosed with mild to moderate carpal tunnel syndrome will be given to both groups in these patients
Study: NCT04298125

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise in Pregnancy
Description: Women in this group will participate in psychical activity 3 times per week in their community setting.
Study: NCT05073900

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Rhomboid intercostal block
Description: two regional anesthesia block techniques are applied

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Rhomboid intercostal block
Description: two regional anesthesia block techniques are applied
Study: NCT02309203

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FRED
Description: Flow Re-Direction Endoluminal Device
Study: NCT05730985

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Miotrof® formula
Description: 1 sachet per day for 4 months

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo formula
Description: 1 sachet per day for 4 months
Study: NCT06302712

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Traditional Islamically Integrated Psychotherapy
Description: Traditional Islamically Integrated Psychotherapy for OCD. We will be using the culturally adapted module of TIIP that is translated into the Urdu language for Pakistan Muslims with OCD. The treatment module is mainly based on four domains Nafs (Behavior), Ihsas (Emotions), Aql (Thought), and Ruh (Spirituality). The session will be conducted in an individual format, with eight sessions, and the intervention will be conducted by a certified therapist in TIIP.
Study: NCT06531096

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: v-DOT
Description: Video directly observed therapy
Study: NCT03900611

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: peripheral electrical stimulation
Description: The subjects will undergo 8-week home-based peripheral electrical simulation on the median nerve. The peripheral electrical simulation will be performed once a day for 30 minutes. The stimulation will be active or sham depend on the group assignment.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: peripheral electrical stimulation
Description: The subjects will undergo 8-week home-based peripheral electrical simulation on the median nerve. The peripheral electrical simulation will be performed once a day for 30 minutes. The stimulation will be active or sham depend on the group assignment.
Study: NCT06113627

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistance Therapeutic Exercise
Description: Strength exercises will be aimed at large muscle groups, such as the shoulder, chest, back and also muscle groups of the lower extremities. In the initial 2 weeks, intervention will start with low intensities of around 55-65% of 1RM, which allows to perform around 15-20 repetitions. The first week there will be performed 2 series, while in the second week it will be 3 series.~Moderate intensity in the 2nd week, corresponding to 65-75% of 1RM and allowing for around 8-12 repetitions. 3 series will be maintained throughout this period of time.In addition to the progressive change in intensity, throughout the intervention the load will be increased by 5-10% when the patient performs the exercise too easily or when they can perform more repetitions than estimated. Rest between sets will be 2-3 minutes.
Study: NCT05020639

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB3820 tablets
Description: TQB3820 is a novel cereblon-modulating agent.
Study: NCT06302855

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: dental expertise
Description: dental visit based on dental expertise
Study: NCT05496881

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Group 1
Description: Prescribed exercises will focus on mobility and balance.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise Group 2
Description: Prescribed exercises will focus on physical fitness.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Exercise Group 3
Description: Prescribed exercises will focus on flexibility, range of motion, and muscle tone.
Study: NCT06302855

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: dental expertise
Description: dental visit based on dental expertise
Study: NCT05544383

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interdisciplinary Pain Education Program
Description: It is an operative group model, with the objective of promoting education in pain, where the patient occupies an active and central space in the learning process, with work focused on the dysfunctional beliefs of chronic pain, performing programmed tasks to promote autonomy in activities daily life and behavior change. The group works with one meeting per week, during the routine opening hours of the clinic, with each day a theme of a professional area being addressed, totaling 5 meetings, lasting approximately two hours.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Physiotherapy treatment
Description: The therapeutic approach consists of rehabilitation methods and techniques, with the aim of restoring, developing and conserving the patient's physical capacity and functionality, including manual therapy and kinesiotherapy, in addition to the use of resources such as electrotherapy, thermotherapy and auriculotherapy. The treatment is performed at the Physiotherapy outpatient clinic, twice a week, with an average duration of 45 minutes, for a period that lasts an average of 10 sessions in clinical cases of chronic musculoskeletal pain.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Physiotherapy treatment
Description: The therapeutic approach consists of rehabilitation methods and techniques, with the aim of restoring, developing and conserving the patient's physical capacity and functionality, including manual therapy and kinesiotherapy, in addition to the use of resources such as electrotherapy, thermotherapy and auriculotherapy. The treatment is performed at the Physiotherapy outpatient clinic, twice a week, with an average duration of 45 minutes, for a period that lasts an average of 10 sessions in clinical cases of chronic musculoskeletal pain.
Study: NCT05465226

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oliceridine
Description: see arm description

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Historical opioid use
Description: Historical matched, control group in 2:1 ratio
Study: NCT05278455

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle Medicine
Description: A smartphone-delivered application with a series of lifestyle medicine components, including lifestyle psychoeducational, physical activity, dietary recommendations, stress management, sleep management, and motivation and goal-setting techniques.
Study: NCT05415410

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apraglutide
Description: Apraglutide is a new, synthetic glucagon-like peptide 2 (GLP-2) receptor agonist which acts as a gut targeted regenerative approach that is intestinotrophic with a mode of action that improves absorption and enhances gut barrier function.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apraglutide
Description: Apraglutide is a new, synthetic glucagon-like peptide 2 (GLP-2) receptor agonist which acts as a gut targeted regenerative approach that is intestinotrophic with a mode of action that improves absorption and enhances gut barrier function.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apraglutide
Description: Apraglutide is a new, synthetic glucagon-like peptide 2 (GLP-2) receptor agonist which acts as a gut targeted regenerative approach that is intestinotrophic with a mode of action that improves absorption and enhances gut barrier function.
Study: NCT06293729

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NGGT006
Description: Single intravenous infusion of NGGT006 at low dose (7.5e12vg/kg), medium dose (1.5e13vg/kg) and high dose (3e13vg/kg).
Study: NCT05987033

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NVDX3
Description: NVDX3 is implanted during a single surgical intervention.
Study: NCT04028700

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: G6PD Deficient Red Blood Cell Transfusion
Description: Patients will receive a red blood cell transfusion. The last 50 mL of the transfusion will be labeled with chromium to allow investigators to study the lifespan of the red blood cells transfused into each patient.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: G6PD Deficient Red Blood Cell Transfusion
Description: Patients will receive a red blood cell transfusion. The last 50 mL of the transfusion will be labeled with chromium to allow investigators to study the lifespan of the red blood cells transfused into each patient.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Non-G6PD deficient Red Blood Cell Transfusion
Description: Patients will receive a red blood cell transfusion. The last 50 mL of the transfusion will be labeled with chromium to allow investigators to study the lifespan of the red blood cells transfused into each patient.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Non-G6PD deficient Red Blood Cell Transfusion
Description: Patients will receive a red blood cell transfusion. The last 50 mL of the transfusion will be labeled with chromium to allow investigators to study the lifespan of the red blood cells transfused into each patient.
Study: NCT06159634

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscopic Submucosal Dissection
Description: Endoscopic submucosal dissection (ESD) will be the technique used to remove target lesions.
Study: NCT06546111

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Drug :placebo tab PO BID for 14 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daflon
Description: Daflon 500 mg tab PO BID for 14 days.
Study: NCT06159634

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic Submucosal Dissection
Description: Endoscopic submucosal dissection (ESD) will be the technique used to remove target lesions.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Traction Device
Description: Use of traction device to aid in removing target lesions
Study: NCT05301751

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AG-73305
Description: AG-73305 Ophthalmic Solution

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AG-73305
Description: AG-73305 Ophthalmic Solution

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AG-73305
Description: AG-73305 Ophthalmic Solution
Study: NCT04942379

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Asthma Link
Description: Providers enroll patients in school nurse supervised daily controller asthma medication delivery
Study: NCT05301751

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AG-73305
Description: AG-73305 Ophthalmic Solution
Study: NCT04942379

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Usual Care
Description: Providers counsel patients on behavioral strategies to improve medication adherence. Patients also receive an asthma workbook outlining behavioral strategies for asthma medication adherence.
Study: NCT04969419

Intervention type: OTHER
Intervention: Exposure of skin cancer of interest
Description: Melanoma and nonmelanoma skin cancers: squamous cell carcinoma, basal cell carcinoma and actinic keratoses.

Intervention type: OTHER
Intervention: Exposure of skin cancer of interest
Description: Melanoma and nonmelanoma skin cancers: squamous cell carcinoma, basal cell carcinoma and actinic keratoses.